The COL6A3 gene provides part of type VI collagen, a supportive protein that helps hold muscles, skin, tendons, and other connective tissues together. This gene plays an important role in keeping the layer around muscle cells strong and flexible. If the gene does not work properly, the body may make weaker collagen, which can lead to muscle weakness, tight joints or overly flexible joints, and sometimes breathing problems. Certain pathogenic variants in the COL6A3 gene are linked to Bethlem myopathy and Ullrich congenital muscular dystrophy.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for building proteins, which are the working parts of cells. Others mainly help determine when, where, and how strongly certain processes take place. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can learn more in the LearnHub.
Overview
COL6A3Gene function
What if the gene works
The COL6A3 gene helps make one part of type VI collagen, a protein that supports muscles and other connective tissues. It helps cells attach to their surroundings and gives tissues strength and flexibility.
Risk
What if the gene does not work
Variants in the COL6A3 gene can cause collagen VI related muscle conditions, most often Bethlem myopathy or Ullrich congenital muscular dystrophy. Effects range from mild joint stiffness and muscle weakness to earlier, more limiting weakness, contractures, and breathing problems.
Treatment
What does that mean for your treatment
No COL6A3-specific treatment or drug-choice approach is currently established for pathogenic variants in the COL6A3 gene. Researchers are studying the COL6A3 gene in collagen VI related muscle conditions as a target for gene based and RNA based therapies, but these approaches remain experimental.
Conditions associated with COL6A3
Gene function
What if the gene works
Your muscles, skin, and tendons need a soft support mesh around their cells to stay steady with movement. The COL6A3 gene helps make one part of that mesh, called collagen VI. This is a key part of how the COL6A3 gene supports connective tissue, helping cells stay connected to their surroundings and tissues stay organized.
The COL6A3 gene provides instructions for one chain of collagen VI, a protein that becomes part of the material between cells. Together with other collagen VI parts, it forms a fine network around cells.
Collagen VI helps cells attach to the surrounding support material and to nearby structures. This anchoring supports cell shape and helps tissues stay connected during everyday movement.
In muscles, skin, tendons, and other connective tissues, collagen VI adds cushioning and flexibility. It helps these tissues handle stretching, pressure, and small mechanical stresses in a more controlled way.
Collagen VI also helps organize the wider support framework around cells by linking with other structural proteins. This keeps the space between cells orderly and supportive.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help create normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the COL6A3 gene can change the size, shape, or amount of the α3 chain, which may impair collagen VI assembly, release from the cell, or stability around cells. Some variants have a mild effect, while more disruptive changes can sharply reduce the protein or create an abnormal chain that disrupts the collagen network. This helps explain how COL6A3 gene variants affect severity, with milder changes linked to later symptoms and stronger effects linked to weakness and stiffness.
How variants are linked to conditions
Variants in the COL6A3 gene are linked to collagen VI-related muscle conditions, especially Bethlem muscular dystrophy and Ullrich congenital muscular dystrophy. Some changes in the COL6A3 gene cause a milder pattern with muscle weakness and joint tightness, while others lead to an earlier-onset condition with greater effects on movement. An intermediate form is also recognized, with features that fall between these two conditions.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well understood variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to COL6A3. For people with a disease-causing change in this gene, risk is mainly shaped by the inherited gene change itself and family history rather than by lifestyle or everyday exposures.
Inheritance of COL6A3 variants
For families trying to understand how COL6A3 gene variants are inherited, the pattern can differ depending on the specific COL6A3 related condition and the type of variant. Some COL6A3 related muscle conditions follow an autosomal dominant pattern, so a parent carrying the variant can pass it to a child with a 50% chance in each pregnancy, and some cases happen because of a new variant not inherited from either parent. Other COL6A3 related conditions follow an autosomal recessive pattern, which usually means a child inherits one variant from each parent.
What does my COL6A3 result mean for my family?
COL6A3 can be linked to more than one inherited muscle condition, so what it means for relatives depends on the exact result. In dominant forms, a parent, brother, sister, or child may also carry the same gene change, though some cases start new in one person. In recessive forms, parents are often healthy carriers, and brothers or sisters may be carriers or, less often, also have the condition.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the COL6A3 gene, COL6A3 genetic testing uses a blood or saliva sample. Laboratories read the DNA code and may also check for missing or extra pieces of the gene. Results can show whether a COL6A3 variant is present and help clarify a COL6A3-related diagnosis.
When should I consider getting a genetic test?
Consider testing the COL6A3 gene if there is unexplained muscle weakness, joint stiffness or very flexible joints, delayed motor milestones, or a family history of an inherited muscle condition linked to COL6A3, such as Bethlem myopathy or Ullrich congenital muscular dystrophy. A result can help confirm the cause and clarify family risk.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains varies with the condition and the kind of variant present. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, it can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person but less well for another, or why some people are more sensitive to side effects. These differences are common and are only one part of the picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medicines. It focuses on patterns between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. Understanding this can support more informed, individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the COL6A3 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding medication choices at this time, so questions about side effects, medicine changes, or your overall health are best discussed with your doctor.
History
Research on collagen VI grew in the 1980s as scientists separated this connective tissue protein into three parts, including the one made from the COL6A3 gene. In recent decades, awareness of this gene’s role has grown. By the early 1990s, researchers had mapped the COL6A3 gene and linked changes in it to inherited muscle and connective tissue conditions that had first been recognized from their physical features. This helped connect older clinical descriptions, such as Bethlem myopathy, with a specific genetic cause. From these first observations, research expanded steadily. Later studies showed that COL6A3-related conditions can vary widely from person to person, which reshaped how doctors classify and follow these conditions.